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Abstract
Background: Guideline development and uptake are still suboptimal; they focus on clinical aspects of diseases
rather than on improving the integration of care. We used a patient-centered network approach to develop five
harmonized guidelines (one multidisciplinary and four monodisciplinary) around clinical pathways in fertility care.
We assessed the feasibility of this approach with a detailed process evaluation of the guideline development,
professionals’ experiences, and time invested.
Methods: The network structure comprised the centrally located patients and the steering committee; a
multidisciplinary guideline development group (gynecologists, physicians, urologists, clinical embryologists,
clinical chemists, a medical psychologist, an occupational physician, and two patient representatives); and four
monodisciplinary guideline development groups. The guideline development addressed patient-centered,
organizational, and medical-technical key questions derived from interviews with patients and professionals.
These questions were elaborated and distributed among the groups. We evaluated the project performance,
participants’ perceptions of the approach, and the time needed, including time for analysis of secondary sources,
interviews with eight key figures, and a written questionnaire survey among 35 participants.
Results: Within 20 months, this approach helped us develop a multidisciplinary guideline for treating infertility
and four related monodisciplinary guidelines for general infertility, unexplained infertility, male infertility, and semen
analysis. The multidisciplinary guideline included recommendations for the main medical-technical matters and for
organizational and patient-centered issues in clinical care pathways. The project was carried out as planned except for
minor modifications and three extra consensus meetings. The participants were enthusiastic about the approach, the
respect for autonomy, the project coordinator’s role, and patient involvement. Suggestions for improvement included
timely communication about guideline formats, the timeline, participants’ responsibilities, and employing a librarian
and more support staff. The 35 participants spent 4497 hours in total on this project.
Conclusions: The novel patient-centered network approach is feasible for simultaneously and collaboratively
developing a harmonized set of multidisciplinary and monodisciplinary guidelines around clinical care pathways
for patients with fertility problems. Further research is needed to compare the efficacy of this approach with more
traditional approaches.
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Background
Complex multidisciplinary care is often fragmented and
suffers from so-called ‘clinical linkage deficiencies’ [1].
To resolve such deficiencies, many published reports and
articles have stressed the importance of implementing
integrated and patient-centered care by building bridges
between the groups involved [2-6]. Clinical practice
guidelines (CPGs) are potential tools for facilitating this
shift in clinical care. Unfortunately, the quality of the
guidelines varies, and their impact on delivering inte-
grated and patient-centered care is still suboptimal [7-12].
Several problems still hinder CPG development and
uptake, namely, inadequate management of conflicts of
interest (COIs), limited panel composition, lack of patient
involvement, and lack of external review [9]. Furthermore,
there is still a strong focus on the single clinical aspects of
diseases described in the guidelines rather than on ensuring
more integrated care for patients, including attention to
matters such as patient-centeredness, coordination and
continuity of care. Because of all this, the target users
feel no affinity with the guidelines, which impedes full
implementation [7,8,10].
Clinical networks are defined as collaborative, profes-
sionalized structures ranging from fully integrated service
delivery systems to informal communities of practice.
These networks have previously proven effective in
increasing evidence-based practice and improving care
models [13,14]. We aimed to resolve the deficiencies in
multidisciplinary guideline (MuG) development and to
re-center the focus on the patient’s overall clinical journey
rather than independent contributions from each specialty
or caring function. Thus, we used the network approach
in a clinical area of complex multidisciplinary care,
namely, fertility care. We developed a harmonized set
of one MuG and four monodisciplinary guidelines
(MoGs) around patient clinical pathways, including any
care needed for infertile couples (such as aftercare and
care given by physicians, gynecologists, and/or urologists).
We aimed to assess the feasibility of this patient-centered
network approach in a detailed evaluation of the process,
professionals’ experiences, and the time required.
Methods
Setting
The Dutch Organization for Health Research and Devel-
opment (ZonMw) funded our project, which took place
within the Dutch program of Knowledge Quality and
Curative Care. The program’s objective was to improve
the development of multidisciplinary CPGs in terms of
innovation, collaboration, and efficiency.
Fertility care
Infertility is commonly defined as ‘any form of reduced
fertility with prolonged time of unwanted non-conception’,
and it affects approximately 80 million couples worldwide
[15,16]. Dutch fertility care takes place on three levels.
Physicians provide primary care that includes an initial
fertility assessment. A physician can refer couples to a
gynecologist in a general hospital (secondary care) or a
university hospital (tertiary care). The gynecologist com-
pletes the fertility assessment, determines the cause of
infertility, and defines a treatment plan. If a relevant male
factor is found, the couple may be referred to an urologist.
Clinical chemists and embryologists are also involved in
assessments and preparation for the use of medically
assisted reproductive techniques, one of which is in vitro
fertilization (IVF). Because infertility has a high emotional
and psychological impact that can interfere with work,
psychologists and occupational physicians are regularly
involved with the clinical course of the infertility problem.
The network
Our steering committee, which included five guideline
experts, one implementation expert, and one project co-
ordinator, initiated and coordinated the patient-centered
network approach to MuG development. A group of gy-
necologists, physicians, urologists, clinical embryologists,
clinical chemists, a medical psychologist, an occupational
physician, and two patient representatives from Freya
(the Dutch association for people with fertility problems)
assembled to collaborate in developing the guidelines
in February 2008. Four MoG groups, including partici-
pants mainly from single disciplines, and one MuG group
convened to develop the guidelines.
An overlap of participants from the same discipline across
the groups and the project coordinator facilitated guideline
harmonization. The project coordinator was a member of
all five groups and gave feedback to the steering committee.
The implementation expert assured attention to the future
implementation and anticipated any potential barriers to
guideline implementation during all development phases.
An independent researcher (MS) evaluated the project.
The network structure consisted of three organized
layers comprising seven groups: the centrally located
infertile patients and the steering committee, the MuG
group, and four MoG groups. For our purposes, this
network was to produce one patient-centered MuG on
infertility and four related, mainly monodisciplinary owned
guidelines. These four included a guideline on general infer-
tility for physicians, a guideline on unexplained infertility
for gynecologists, a guideline on male infertility for urolo-
gists and gynecologists, and a guideline on semen analysis
for clinical embryologists.
Guideline development
Managing conflicts of interest (COIs)
Before starting the guideline development, all members
of the groups had to declare any COIs and be officially
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mandated by their societies. The steering committee
discussed all COIs. Participants with significant COIs
were excluded from discussions or voting on recom-
mendations for which they had COIs.
Defining the scope and key questions
We explored the care aspects in the clinical pathways of
infertile patients. We paid particular attention to improve-
ments that the patients and professionals found necessary.
Various methods were used to collect data about the most
relevant aspects.
We conducted 12 exploratory interviews with couples
facing the spectrum of issues in the main phases of the
clinical pathways in fertility care. These phases may
include a physician’s initial fertility assessment, a gyne-
cologist’s fertility assessment, treatment with ovulation
induction, intrauterine insemination, IVF, and/or intracy-
toplasmic sperm injection by a gynecologist, a urologist’s
care, and aftercare (whether pregnancy occurred or not).
The couples were consecutively invited to participate
by means of an information letter that they received
when they saw a gynecologic resident in a fertility clinic
in Nijmegen or Amsterdam. We phoned potential par-
ticipants—Dutch-speaking couples with fertility problems
who reacted positively to the information letter. The selec-
tion of couples was random except for their phase in the
clinical pathway. The steering committee translated care
aspects that the couples said needed improvement into
patient-centered key questions.
Two focus groups were conducted among members of
the MuG group, including the two patient representatives,
and among main target users of the guideline, including
four gynecologists, three physicians, and a urologist. The
steering committee translated care aspects that the profes-
sionals said needed improvement into medical-technical,
organizational, and patient-centered key questions. Ex-
ample questions for these three categories, respectively,
are: ‘What are the indications for IVF treatment?’ ‘Which
professionals should be part of the treatment team in a
university hospital?’ ‘How should patients be informed
about adoption?’
All key questions were given a format defined for the
MuG. Then the MoG groups addressed the medical-
technical questions and the MuG group addressed the
organizational and patient-centered questions.
Elaborating key questions and formulating
recommendations
The participants worked in pairs. They used the PICO
(patient, intervention, comparison, and outcome) method
to define their search strategy, conduct a systematic litera-
ture review, select relevant evidence, and summarize this
evidence in formatted evidence tables. They rated (scale: 1
to 5) the evidence according to quality criteria adapted
from the Center for Evidence-Based Medicine, version
1999 [17]. The pairs of members then formulated one or
more conclusions, their considerations, and one or more
concept recommendations. A level of evidence (A to D)
was given for each recommendation to be discussed in the
particular guideline group [17]. The project coordinator
was a member of all guideline groups and coordinated
the entire process, which was part of a strategy for
harmonizing recommendations across the groups. The
project coordinator checked the rating of evidence and
grading of recommendations for errors. The steering
committee discussed and resolved any discrepancies.
The implementation expert checked and improved the
implementability of the concept recommendations and
the guidelines as a whole using the items of the Guideline
Implementability Appraisal (GLIA) Tool. An extensive
internal review of the CPGs across the groups was used
to harmonize the recommendations. Many patients also
participated by formulating and prioritizing recommen-
dations for the MuG [18].
We used advertisements and mailings over a period
of seven months to invite patients with fertility problems
to formulate recommendations via the Dutch online
wiki-based tool at www.freyawiki.nl [18]. A patient rep-
resentative and two members of the steering committee
including the implementation expert modified and assessed
the implementability of the patient recommendations with
the GLIA Tool. Then we asked patients to select their
top three or five recommendations for each wiki section
(General care, General practice care, Gynecologic care,
Urologic care, and Laboratory) [18]. The guideline group
assessed the eligibility of the final set of patients’ recom-
mendations within the scope of the guideline.
Integrating the guidelines
The MoGs addressed medical-technical aspects of care
that needed improvement: physician care, care for patients
suffering from unexplained infertility or male infertility,
and fertility care given by clinical embryologists (semen
analysis). The definitive MuG described the overall clinical
pathway of patients with fertility problems by merging
the main medical-technical, patient-centered, and organ-
izational recommendations from the MuG and MoG
groups and the prioritized patient recommendations from
WikiFreya [18]. The medical-technical recommendations
included transitions in fertility care and care alignment.
The patient-centered recommendations dealt with respect
for patients’ values, preferences, and needs; information,
communication, and education; emotional support; partner
involvement; and the attitude of the fertility clinic staff.
The organizational recommendations addressed coordin-
ation and integration of care, physical comfort, transition
and continuity of care, access to care, and staff competence
and technical skills. All patient recommendations obtained
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via WikiFreya were classed as Level P (Patient) evidence.
To express patients’ input in the guideline, two patient
representatives reformulated patient recommendations
as: ‘Patients want to….’ The whole project was planned
to be completed in 18 months.
Evaluation
We applied a stepwise process evaluation to the feasibility
of this network approach [19]. The primary outcomes
were ‘how’ the planned project was actually carried out
and ‘how’ participants perceived the process; the second-
ary outcome was ‘what’ time was invested. We used a
mixed-method evaluation including examination of sec-
ondary resources (such as project descriptions), interviews
with key figures, and a written questionnaire survey
among all participants. An independent researcher (MS)
conducted the interviews and collected the data.
Data collection
Examination of secondary resources
We collected all the project data from the project descrip-
tions and minutes of meetings to determine whether the
project was carried out as planned.
Interviews with key figures
We conducted eight semistructured, in-depth, telephone
interviews with eight key figures: the chairpersons of the
four MoG groups, four members of the MuG group, and
the steering committee (one patient representative, two
project leaders, and the project coordinator). We asked
the interviewees to chronologically describe the guide-
line development and their activities in the project. We
asked for comments on the overall organization, the
methodology of the network approach, the methods of
patient involvement. Then we asked for suggestions to
improve the approach. Full interviews took approxi-
mately 30 min each, and they were fully transcribed
verbatim.
Questionnaire survey
We based our questionnaire on the interview results
so that we could assess participant experiences and
measure the time needed for the project. The first part
of the four-part questionnaire asked about participants’
background characteristics. The second part pertained to
participants’ involvement in the preparation and develop-
ment phase and the time (excluding travel) needed for
each of these phases. The third part included five open
questions about the network approach (e.g., the method-
ology and guideline integration), patient involvement, wiki
methodology, and patient contributions to the guideline.
The fourth part asked participants to describe facilitators
of and barriers to the approach and to suggest improve-
ments. All participants received the questionnaire by post,
after the draft guidelines were completed. A reminder was
sent six weeks later.
Data analysis
We used SPSS (version 16.0 for Windows, Data Entry
4.0, SPSS, Chicago, Ill.) to perform descriptive statistics
(frequencies, medians, and ranges) on participant back-
ground characteristics and to analyze the time data. We
used Kwalitan (version 5.0, Malden, The Netherlands)
to qualitatively analyze the transcripts of the interviews
and the free text responses from the second part of the
questionnaire [20].
Project performance
Two authors (MH and RH) identified all activities and cate-
gorized them in the preparation phase or the development
phase. The preparation phase included composing develop-
ment groups, managing COIs, identifying care aspects to
be improved, and developing WikiFreya. The development
phase included attending meetings, formulating key ques-
tions, reviewing, selecting and assessing evidence, writing
the guideline and formulating recommendations, harmon-
izing the guidelines, reviewing and revising draft guidelines,
and aligning the guidelines with managing WikiFreya. We
compared the actual activities with the planned activities
and identified differences.
Time investments
We counted the regular and extra meetings on the attend-
ance lists, and determined the mean meeting participation
rates for each group and the steering committee. We cal-
culated the total time the steering committee spent on the
preparation phase. We computed the median actual time
for the respondent meetings of each development group,
total time for extra respondent meetings, and median
extra time respondents spent for each development group
and for each of the two phases. The total time for meet-
ings for each group, including the project coordinator was
assessed as the ‘mean participation rate’ x ‘number of
meetings’ x ‘median time investments’. The total extra
time needed was defined as the ‘number of participants
for each group’ x ‘median extra time spent by each partici-
pant’. The values were corrected for non-responders to
the questionnaire. We calculated the project coordinator’s
extra time separately. Our calculations totaled the time
needed for the development phase.
Experiences
We analyzed the data descriptively, and we used a special
framework to analyze open question responses. We devel-
oped the special framework from the interview topic guide
corresponding to our study objectives, which included
experience with the methodology of the network approach,
patient involvement, barriers to and facilitators of the
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approach, and suggestions for improvement [21]. Two
researchers (EB and MH) studied the interviews and the
open question responses independently. They identified
and coded the parts of the interviewees’ responses that
were relevant to the study objectives. They then discussed
key issues and discrepancies between their results. The
key issues were structured with a view to the study ob-
jectives. The questionnaire was based on the interviews,
so we only present the results of the questionnaire for
each study objective, but no information found under
the heading ‘Organization’.
Results
Participants
Five (four MoG and one MuG) groups were installed in
May 2008. None of the members of the groups declared
significant COIs, and all of them were officially mandated
by their societies. One of the physicians involved in the
MuG group dropped out for private reasons two months
later. The MuG chairperson, a physician, concurrently
fulfilled this role. Overall, 32 participants were involved
in the five groups (Table 1). Four participants fulfilled
multiple roles: the project coordinator was a member
of the steering committee and all five guideline groups;
the chairperson of the MoG group for general infertility
was a member of the steering committee; one project
leader was a member of the steering committee and chair-
person of the MuG group; and one member of the MuG
group was a member of the steering committee (Table 1).
All participants received the evaluation questionnaire
(one patient representative was unavailable). The response
rate was 79% (n = 27). Table 2 summarizes the background
characteristics of the respondents. Of the 59% who were
experienced in guideline development, 63% were also ex-
perienced in MuG development.
Guideline development
The project was carried out as planned, except for minor
modifications needed to improve the consistency between
the concepts of the guidelines. Face-to-face meetings and
additional conferences calls were necessary to discuss
discrepancies between recommendations concerning the
cut-off points for treating infertility. These recommenda-
tions were issued by guidelines for male infertility and
unexplained fertility. The cut-off points were eventually
based on the existing relevant evidence. Further, there was
a lack of consensus on some recommendations in the four
MoGs for life-style advices (e.g., alcohol and anabolic
steroids use) issued in all four MOGs as well as lack of
and a lack of underlying evidence. This necessitated
two additional consensus meetings, which were attended
by four members of the MuG (including the chairperson)
and the chairpersons of all MoG groups. These consensus
meetings produced overall recommendations for life-style
advice based on evidence regarding pre-pregnancy coun-
seling. The MuG group reviewed the drafts of the MoG
groups and vice versa. Then, the project coordinator initi-
ated a conference call in order to reach consensus on
the recommendations based on the expert opinion of
the MoGs. Via WikiFreya, 298 patients formulated 289
recommendations, which 80 patients prioritized into 21
recommendations. These recommendations were included
in the definitive guideline [18].
Resulting guidelines
One MuG and four related MoGs were developed in
20 months; all were written in Dutch:
http://www.nvog-documenten.nl/uploaded/docs/
Landelijke%20netwerkrichtlijn%20Subfertiliteit%20def.pdf
www.nvog.nl
www.nhg.org
Table 1 Organizations in the guideline development groups
Professional societies Number of members in development groups
Multidisciplinary
guideline
MoG: general
infertility
MoG: unexplained
infertility
MoG: male
infertility
MoG: semen
analysis
Dutch Association of Obstetrics & Gynecology 2 1 4 2 1
Dutch National Organization of General Practitioners 2 5 1 1 0
Dutch Urological Association 1 0 0 2 0
Dutch Society for Clinical Embryologists 1 0 0 0 2
Dutch Society for Clinical Chemistry 1 0 0 0 1
Dutch Society of Occupational Physicians 1 0 0 0 0
Dutch Association of Psychologists 1 0 0 0 0
Dutch Patient Association for Fertility Problems 2 0 0 0 0
Number of participants 11 6 5 5 4
Total number of participants = 31a
aThe project coordinator took part in all working groups, which increased the total number of participants by one.
MoG =Monodisciplinary guideline.
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www.nvu.nl
www.embryologen.nl
The definitive MuG follows the overall clinical care
pathway for patients with infertility problems. It addresses
patient-centered, organizational, and medical-technical
issues on the clinical pathways, from first visiting the
physician to completed treatment (with or without a
pregnancy) and aftercare from the physician or medical
psychologist (Table 3). The MuG consists of 198 rec-
ommendations based on the best available evidence or
expert opinion; the level of evidence (A to D) is given for
each recommendation. All recommendations were linked
to the key questions formulated. Of these recommenda-
tions, 59% concerned organizational and patient-centered
aspects of care (Table 4). The medical-technical recom-
mendations for transitions in fertility care and supporting
care alignment were derived from the MoGs. Twenty-one
prioritized patients’ recommendations, obtained via Wiki-
Freya, were included in the MuG and graded as level P
evidence [18].
Time investments
The median number of two-hour regular group meetings
was 10 (range: 5 to 11). The median participation rate was
88% (range: 77 to 94%). Three additional two-hour meet-
ings were necessary for adjustment between guidelines.
The steering committee needed 11 two-hour meetings for
organizing the project.
Seven participants (20%) were involved in the prepar-
ation phase, for which they needed 471 h in total. In
the development phase, the participants spent time on
meeting preparation, two-hour face-to-face meetings,
and minutes of meetings; and extra time on reviewing
literature, writing guidelines, and commenting on draft
versions. The time all participants spent in the develop-
ment phase totaled 4,497 hours, including the 281 hours
the steering committee members spent organizing this
phase (Table 5).
Feedback
Interviews
Most of the eight interviewees thought the guideline
groups were well composed. Nevertheless, they perceived
combining the role of moderating the meetings and pro-
viding clinical input for the content as unsatisfactory. The
two project leaders said they underestimated the project
coordinator’s workload, particularly in combining the
coordination tasks with writing the draft guidelines.
Furthermore, views and preferences differed between
the chairperson of the MuG and the project coordinator
about the scope, format, and content of the guideline;
this formed a time-consuming barrier.
Questionnaires
The 27 questionnaires showed that most participants
perceived the methodology of the network approach on
the one hand as ‘the promising future of guideline devel-
opment’ and on the other hand as ‘complex and unclear’.
Positive notes included the perceived individual learning
curves for guideline development, the opportunity of
distributing key questions to participants with relevant
knowledge, various participants’ perceived respect for
autonomy, and the collaborative development of the one
MuG. Furthermore, participants reported that the high
level of coordination required to carry out the project as
planned was a potential barrier to the approach. The
different opinions among the professionals caused delays
and tension in finalizing the guidelines. Clear expectations
about the roles of the participants and a description of the
final format for the guideline were lacking.
The integration of the MoGs into the MuG was seen as
‘powerful’, mainly regarding ‘special attention to transitions
in different phases of care (alignment)’, ‘the opportunity to
check possibly underexposed topics’ and ‘the simultaneous
development of all guidelines’. The final equalization of
guideline content was ‘too late’ (e.g., when recommen-
dations had already been formulated), ‘difficult’ (due to
differing opinions), and ‘time consuming’ (extra meetings).
One respondent said integrating MoGs into the MuG was
‘needless’.
Patient involvement
All MuG group respondents described the participation
of patient representatives in their group as ‘valuable’ (e.g.,
influencing discussions by refocusing on the patient) and
their contributions as ‘beneficial to the final product’ (e.g.,
Table 2 Background characteristics of questionnaire
respondents
27 respondents n (%)
Gender
Male 14 (52)
Female 13 (48)
Age in years
26–35 4 (15)
36–45 9 (33)
46–55 11 (41)
>55 3 (11)
Median years of professional experience in
fertility care (range)
9 (1–26)
Previous experience in guideline developmenta
Yes 16 (59)
No 11 (41)
MoG =Monodisciplinary guideline, MuG =multidisciplinary guideline.
aExperience in guideline development was determined by the authorship of
one or more monodisciplinary or multidisciplinary guidelines.
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affecting formulations of considerations or expert-based
recommendations). The representatives emphasized the
need for information about the components of clinical
care pathways before they discussed treatment options.
More than one-half the respondents described the final
patient recommendations as ‘valuable’ or ‘eye-openers’, and
‘useful’ in formulating professional recommendations.
Some of them doubted the practical applicability of these
recommendations. They questioned the fact that patients
recommended that the physician immediately refer patients
trying to conceive to the gynecologist. They noted the lack
of new insights in patient recommendations.
Facilitators and barriers
Facilitators for the network approach included the selec-
tion of the most competent and dedicated participants,
Table 3 Contents of the final version of the patient-centered multidisciplinary guideline for infertility
Chapter 1: background Description of the patient-centered network approach
Composition of the guideline development groups and methods used to involve patients
Definition of infertility and description of patients’ clinical pathway
Chapter 2: organization Organization of fertility care
Registration of outcomes of infertility treatments
Care alignment
Chapter 3: physician Basic principles in fertility care for the physician
History, physical examination, and additional infertility assessments
Treatment policy
Referral
Information provision and education
Coordination of primary care with secondary/tertiary care
Attendant role after referral
Chapter 4: gynecologist Basic principles of fertility care for the gynecologist
History, physical examination, and additional infertility assessments
Treatment policy
Treatment criteria regarding age
Information provision and education
Referral
Coordination of primary care with secondary/tertiary care
Chapter 4: urologist Basic principles of fertility care for the urologist
History, physical examination, and additional infertility assessments
Treatment policy
Coordination of primary care with secondary/tertiary care
Chapter 5: semen analysis Basic principles for semen analysis
Collection of semen
Analyzing the semen
Interpreting the results of a semen analysis
Reporting the results
Chapter 6: psychologist Basic principles in fertility care for the psychologist
Psychological screening of patients with fertility problems
Referral
Chapter 7: sexologist
Chapter 8: work and infertility Infertility in relation to occupation
Exposure to harmful substances during work
Participation of infertile patients in work
Chapter 9: associations for fertility problems Opportunities and legislation for adoption
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the introduction of the project coordinator, and patient
contributions. Perceived political barriers, competing pro-
fessional interests of those involved, and the lack of a
more detailed MuG format created barriers. Sugges-
tions for improvement included communication of clear
instructions for individual roles and responsibilities, a
strict schedule including deadlines, and a clear format for
the guidelines. Further, the need for supportive staff and
support for literature searches were noted.
Discussion
This study provides detailed insight into the feasibility
of a novel patient-centered network approach to MuG
development for fertility care. This approach enabled
the collaborative development of a harmonized set of
one MuG and four MoGs for clinical care pathways for
infertile couples. The approach helped us foresee possible
barriers analogous to the US Institute of Medicine recom-
mendations for developing trustworthy and transparent
CPGs [9].
All the relevant stakeholders were included in the
guideline groups. Collaboration between balanced groups
of key stakeholders is an important success factor for
clinical networks and may lead to a more valid method
of developing guidelines [9,10]. A crossover of stakeholders
from one guideline group to another helped harmonize the
guideline content and distribute questions among the
groups. This emphasized specific professional contribu-
tions and created a feeling of affinity with the guidelines.
The development required intensive patient engagement,
and the contributions of patient representatives in the
MuG group and individual patients acting via WikiFreya
were considered valuable [18].
The MuG follows patient clinical pathways and uses a
network structure that includes all stakeholders, so that
it pays much attention to the organization of the different
phases of fertility care and transitions from one phase to
another. This ensures better-integrated care (e.g., referral
from the physician to the gynecologist) [22]. The atten-
tion to patient preferences, needs, and values may have
increased the level of patient-centeredness [23]. The
approach included an extensive review of the guidelines
throughout the development. It used the network structure
for which extra time was needed, but it enabled broader
support of the guidelines and may enhance future guideline
implementation [24,25].
The participants liked the approach and viewed it as
a promising format for developing MuGs. Enthusiastic
patients and the energetic project coordinator helped
make the approach work well. Suggestions for improving
the approach were reported mainly at the organizational
level (e.g., previous communication about individual
roles and responsibilities, a detailed time line, and a de-
tailed format for the guidelines). This correlates with
the existing literature about clinical networks, which
implies that using clinical networks requires a high
degree of managerial organization [13,14,22,26]. More
support staff might enhance the efficiency of the network
approach. Engaging a librarian to help with literature
searches might accelerate guideline development and
Table 4 Examples of recommendations integrated into the multidisciplinary guideline
Medical-technical recommendations Origin or guideline Chapter of the MuG
The physician should only physically examine the man if his semen
analysis is irregular. LOE C
General infertility for physicians Family physician (physical examination)
The gynecologist should not test ovarian reserve capacity to predict
probability of pregnancy (with or without treatment). LOE A
Unexplained infertility Gynecologist (assessments)
Organizational recommendations
The physician should order a semen analysis from an accredited
laboratory (ISO15189) or from a referral hospital. LOE D
MuG Organization of fertility care
In accordance with the Dutch IVF planning decree, every licensed IVF center
and their corresponding transport and satellite centers must provide annual
reports on treatment outcomes for uniform national IVF registration. LOE D
MuG Organization of fertility care (registration)
Patient-centered recommendations
Both partners of the couple should be involved in the assessment
and management of infertility because it is a joint problem. LOE C
MuG Physician, gynecologist, and urologist
(basic principles)
The gynecologist should offer couples with fertility problems
psychological support throughout all phases of fertility care. LOE D
MuG Gynecologist (information provision)
Patient recommendations
Patients want their gynecologist to inform them about the
different phases of treatment and their expected time spans. LOE P
MuG Gynecologist (information provision)
Patients want their physician to make a referral immediately after
they have been trying to conceive for 1 year. LOE P
MuG physician (referral)
MuG =Multidisciplinary Guideline, IVF = in vitro fertilization, LOE = level of evidence.
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Table 5 Time investments for phase 2: guideline development
Guideline development
groups and number
of participants
Mean percentage of
participation in regular
meetings (number
of meetings)
Median hours spent
per participant in
regular meetings
(range)
Total hoursa spent
in regular meetings
per development
group
Total hours in
additional meetings
(number of
participants)
Median extra
hours per
participant (range)
Total extra hoursb
per development
group
Total hoursc in
the development
phase
MoG: general infertility; n = 7 92 (10) 40 (22.5–50) 258 7 (1) 58 (40–60) 348 613
MoG: unexplained infertility;
n = 6
85 (10) 47 (18–72) 240 15 (3) 58 (50–60) 290 545
MoG: male infertility; n = 6 94 (8) 24 (12–56) 135 8 (2) 39 (18–50) 195 338
MoG: semen analysis; n = 5 88 (5) 30 (10–35) 132 - 48 (46–50) 192 324
MuG; n = 11 77 (11) 30 (21–55) 254 38 (10) 31 (2–51) 310 602
Subtotal 1019 68 1335 2422
Steering committee n = 7 87 (11) 25 (15–77) 152 39 (4) 15 (3–52) 90 281
Project coordinatorc 1794c 1794c
Total 1171 107 3219 4497
MoG =Monodisciplinary guideline, MuG =multidisciplinary guideline.
Regular meetings are meetings necessary for the development of the guidelines.
Additional meetings are meetings necessary for discussing and refining the consistency of the guidelines.
Extra time investments are the hours participants needed to formulate key questions, review, select and assess evidence, write, review and revise draft guidelines, secure alignment of the guidelines and
manage Wikifreya.
aTotal hours for regular meetings are corrected for questionnaire non-responders (mean participation rate x number of meetings x median time investments).
bTotal extra hours are corrected for questionnaire non-responders [(number of participants per development group-1) x median extra time per participant].
cThe project coordinator’s meeting hours are included per development group; his extra hours are given separately.
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increase efficiency [27]. However, the approach seemed
time consuming for developing our set of five related
guidelines simultaneously. Unfortunately, it is difficult
to compare our time investments with those of regular
guideline development, since there is a dearth of pub-
lished studies about this topic.
Strengths and limitations
Although the use of a clinical network has been suggested
as an effective strategy for implementing CPGs, this is
the first study that has applied this approach in devel-
oping MuGs [28-31]. Our guideline development closely
paralleled the main recommendations of the US Institute
of Medicine [9]. However, recommendations were not
graded and to express patients’ input, patients’ recommen-
dations were secondarily reformulated to a non-actionable
form incongruent to the GLIA instrument. This non-
actionable form could impede harmonization of patients
and stakeholders generated inputs. In addition to other
studies on guideline development approaches, we also
evaluated the feasibility of the approach. Nevertheless,
a basis for comparing time data is lacking, which is a
limitation of our study and a major limitation of current
study designs of guideline development. In our opinion,
guideline development is time consuming and expensive.
Time should always be weighed against benefits, especially
for introducing new approaches.
We have applied the patient-centered network approach
to a MuG program for fertility care. This clinical area is
characterized by the involvement of intensively collaborat-
ing professionals and responsible patients, which might be
an argument against generalizability for other clinical
areas. However, addressing practice change and sustaining
clinical networks generally requires great motivation and
is not specific to fertility care [32,33]. In this light, the level
of our participants’ experience may have been a success
factor in realizing the project in a relatively short time,
but it may also be an argument against generalizability.
Nevertheless, basic knowledge of guideline development
methodologies is necessary in all approaches. Moreover,
not only were our participants pretty experienced in
guideline development, they were also opinion leaders
within their own medical specialties. This may be an
important success factor for disseminating and imple-
menting the definitive guidelines. Despite this, we realize
that, because our participants are rather experienced in
their own usual way of developing guidelines, they might
have been more critical of such a new approach. For
instance, they regarded the lack of a detailed format as a
barrier. This factor may have hindered the guideline
development.
Although the guidelines clearly address organizational
and patient-centered aspects (altogether, in 59% of the
recommendations), we did not compare the proportion
of these aspects to proportions in conventionally devel-
oped guidelines. However, we expect that the proportion
of patient-centered aspects is rather small in other guide-
lines because patient participation in guideline develop-
ment is still not common practice [34]. This mechanism
may also apply to the organizational aspects, which are
mainly addressed in guideline-related products, such as
local protocols.
Although the participating member societies and orga-
nizations are committed to disseminating the final, har-
monized guidelines, our detailed process evaluation was
limited to the first phases of the guideline development
and did not include the dissemination and implementation
phases. We assume that this approach will enhance the im-
plementation and our network might be an effective strat-
egy in the further efforts that are still required [28-32,35].
Conclusions and implications for further research
The novel approach of the patient-centered network is
feasible for simultaneously and collaboratively developing
a harmonized set of MuGs and MoGs for the clinical
pathways of infertile couples. The approach is a potential
strategy for developing more trustworthy and transparent
guidelines. If consensus on the guideline format is reached
beforehand, instructions on individual responsibilities
within the network are provided, more support staff is
employed, and a librarian is engaged to conduct system-
atic literature searches, then the network approach can be
used in other guideline development programs too.
We believe that this approach may apply especially to
patients who travel numerous complex pathways. Our
study focuses on the network needed for patients who
receive multidisciplinary fertility care and form the cen-
ter of the network. However, other patients who travel
different or multiple complex clinical pathways may also
profit from this approach. Multiple networks can be
connected or extended where necessary. However, this
approach might be less valuable when patients travel a
clear monodisciplinary pathway; for example, the pathway
for a simple bone fracture. Further research is needed to
compare the efficacy of this approach with more trad-
itional approaches regarding content, time investments,
and actual adoption of guidelines in a pragmatic random-
ized controlled trial.
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